Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

Taiwan · Delayed Price · Currency is TWD

7.95

-0.07 (-0.87%)

Aug 26, 2026, 12:14 PM CST

-28.38% (1Y)

Market Cap	715.50M -28.4%
Revenue (ttm)	348.54M -6.3%
Net Income	15.76M -32.7%
EPS	0.18 -26.4%
Shares Out	90.00M
PE Ratio	43.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	219,257
Open	7.64
Previous Close	8.02
Day's Range	7.61 - 8.39
52-Week Range	6.92 - 17.65
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About TPEX:4186

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA and rapid test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers stem cell banking services for newborn and adult stem cells storage; cell therapy programs; abused drugs rapid tests... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1989

Employees 160

Stock Exchange Taipei Exchange

Ticker Symbol 4186

Full Company Profile

Financial Performance

In 2025, TPEX:4186's revenue was 364.79 million, an increase of 3.00% compared to the previous year's 354.17 million. Earnings were 28.05 million, an increase of 22.61%.

Financial Statements